Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1372

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1372
---
 Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report
to be signed on its behalf by the undersigned, thereunto duly authorized.

    Channel
    Therapeutics Corporation

    Date:
    March 27, 2025
    By:
    /s/
    Francis Knuettel II

    Name:
    Francis Knuettel II

    Title:
Chief Executive Officer and President, Chief Financial Officer, Treasurer and Secretary
        
        (Principal
Executive Officer, Principal Financial Officer, Principal Accounting Officer)

Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf
of the registrant and in the capacities and on the dates indicated.

    Date:
    March 27, 2025
    By:
    /s/
    Francis Knuettel II

    Francis Knuettel
    II

    Chief
Executive Officer and President, Chief Financial Officer, Treasurer, Secretary and Director

    Date:
    March 27, 2025
    By:
    /s/
    Ezra Friedberg

    Ezra Friedberg

    Director

    Date:
    March 27, 2025
    By:
    /s/
    Todd Davis

    Todd Davis

    Director

    Date:
    March 27, 2025
    By:
    /s/
    Richard Malamut

    Richard Malamut

    Director

    Date:
    March 27, 2025
    By:
    /s/
    Chia-Lin Simmons

    Chia-Lin Simmons

    Director

109 

CHANNEL
THERAPEUTICS CORPORATION 

INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS 

    Page

    Report of Independent Registered Public Accounting Firm (PCAOB ID 688)
    F-2

    Audited Financial Statements

    Consolidated Balance Sheets
    F-3

    Consolidated Statements of Operations
    F-4

    Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
    F-5

    Consolidated Statements of Cash Flows
    F-6

    Notes to the Consolidated Financial Statements
    F-7

F-1 

REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To
the Shareholders and Board of Directors of 

Channel
Therapeutics Corporation